Induction of Functional IL-8 Receptors by IL-4 and IL-13 in Human Monocytes1

IL-8 and related Glu-Leu-Arg (ELR+) CXC chemokines are potent chemoattractants for neutrophils but not for monocytes. IL-13 and IL-4 strongly increased CXCR1 and CXCR2 chemokine receptor expression in human monocytes, macrophages, and dendritic cells. The effect was receptor- and cell type-selective, in that CCRs were not increased and no augmentation was seen in neutrophils. The effect was rapid, starting at 4 h, and concentration dependent (EC50 = 6.2 and 8.3 ng/ml for CXCR1 and CXCR2, respectively) and caused by new transcriptional activity. IL-13/IL-4-treated monocytes showed increased CXCR1 and CXCR2 membrane expression. IL-8 and related ELR+ chemokines were potent and effective chemotactic agents for IL-13/IL-4-treated monocytes, but not for untreated mononuclear phagocytes, with activity comparable to that of reference monocyte attractants, such as MCP-1. In the same cells, IL-8 also caused superoxide release. Macrophages and dendritic cells present in biopsies from Omenn’s syndrome and atopic dermatitis patients, two Th2 skewed pathologies, expressed IL-8 receptors by immunohistochemistry. These results show that IL-13 and IL-4 convert IL-8 and related ELR+ chemokines, prototypic neutrophil attractants, into monocyte chemotactic agonists, by up-regulating receptor expression. Therefore, IL-8 and related chemokines may contribute to the accumulation and positioning of mononuclear phagocytes in Th2-dominated responses.

[1]  A. Mantovani,et al.  The chemokine system: redundancy for robust outputs. , 1999, Immunology today.

[2]  F. Rossi,et al.  β-Amyloid Activates the O⨪2 Forming NADPH Oxidase in Microglia, Monocytes, and Neutrophils , 1999, The Journal of Biological Chemistry.

[3]  F. Rossi,et al.  beta-amyloid activates the O-2 forming NADPH oxidase in microglia, monocytes, and neutrophils. A possible inflammatory mechanism of neuronal damage in Alzheimer's disease. , 1999, The Journal of biological chemistry.

[4]  F. Luscinskas,et al.  MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions , 1999, Nature.

[5]  S. Goerdt,et al.  Other functions, other genes: alternative activation of antigen-presenting cells. , 1999, Immunity.

[6]  A. Lentsch,et al.  Regulation of acute lung inflammatory injury by endogenous IL-13. , 1999, Journal of immunology.

[7]  M Locati,et al.  Chemokines and chemokine receptors: biology and clinical relevance in inflammation and AIDS. , 1999, Annual review of medicine.

[8]  C. Mackay,et al.  Up-regulation of CCR1 and CCR3 and induction of chemotaxis to CC chemokines by IFN-gamma in human neutrophils. , 1999, Journal of immunology.

[9]  R. Badolato,et al.  Expression of inducible nitric oxide synthase in human granulomas and histiocytic reactions. , 1999, The American journal of pathology.

[10]  M. Rihanek,et al.  STCP-1 (MDC) CC chemokine acts specifically on chronically activated Th2 lymphocytes and is produced by monocytes on stimulation with Th2 cytokines IL-4 and IL-13. , 1998, Journal of immunology.

[11]  P. Allavena,et al.  Divergent effects of interleukin-4 and interferon-gamma on macrophage-derived chemokine production: an amplification circuit of polarized T helper 2 responses. , 1998, Blood.

[12]  D. Kelvin,et al.  CXCR1 and CXCR2 are rapidly down-modulated by bacterial endotoxin through a unique agonist-independent, tyrosine kinase-dependent mechanism. , 1998, Journal of immunology.

[13]  C. Bruijnzeel-Koomen,et al.  A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. , 1998, Immunology today.

[14]  O. Yoshie,et al.  Identification of Single C Motif-1/Lymphotactin Receptor XCR1* , 1998, The Journal of Biological Chemistry.

[15]  D. Dichek,et al.  Adhesion of monocytes to vascular cell adhesion molecule-1-transduced human endothelial cells: implications for atherogenesis. , 1998, Circulation research.

[16]  J. Bousquet,et al.  Cutting Edge: IL-4 Induces Functional Cell-Surface Expression of CXCR4 on Human T Cells , 1998, The Journal of Immunology.

[17]  A. Sica,et al.  Selective inhibition of expression of the chemokine receptor CCR2 in human monocytes by IFN-gamma. , 1998, Journal of immunology.

[18]  D. Weissman,et al.  Dendritic cells express multiple chemokine receptors used as coreceptors for HIV entry. , 1998, Journal of immunology.

[19]  M. Baggiolini Chemokines and leukocyte traffic , 1998, Nature.

[20]  C. Mackay,et al.  Interleukin 10 Increases CCR5 Expression and HIV Infection in Human Monocytes , 1998, The Journal of experimental medicine.

[21]  S. Goerdt,et al.  Alternative macrophage activation-associated CC-chemokine-1, a novel structural homologue of macrophage inflammatory protein-1 alpha with a Th2-associated expression pattern. , 1998, Journal of immunology.

[22]  R. Terkeltaub,et al.  A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice. , 1998, The Journal of clinical investigation.

[23]  P. Proost,et al.  Interleukin-8 and other CXC chemokines , 1998 .

[24]  P. Allavena,et al.  Chemokines and chemokine receptors during activation and deactivation of monocytes and dendritic cells and in amplification of Th1 versus Th2 responses , 1998, International journal of clinical & laboratory research.

[25]  J. Bousquet,et al.  IL-4 induces functional cell-surface expression of CXCR4 on human T cells. , 1998, Journal of immunology.

[26]  T. Mayadas,et al.  A Role for Mac-1 (CDIIb/CD18) in Immune Complex–stimulated Neutrophil Function In Vivo: Mac-1 Deficiency Abrogates Sustained Fcγ Receptor–dependent Neutrophil Adhesion and Complement-dependent Proteinuria in Acute Glomerulonephritis , 1997, The Journal of experimental medicine.

[27]  O. Götze,et al.  The CXC-chemokine neutrophil-activating peptide-2 induces two distinct optima of neutrophil chemotaxis by differential interaction with interleukin-8 receptors CXCR-1 and CXCR-2. , 1997, Blood.

[28]  P. Allavena,et al.  Human monocyte‐derived and CD34+ cell‐derived dendritic cells express functional receptors for platelet activating factor , 1997, FEBS letters.

[29]  D. Kelvin,et al.  Regulation of CCR2 chemokine receptor mRNA stability , 1997, Journal of leukocyte biology.

[30]  M. Gobbi,et al.  Receptor expression and responsiveness of human dendritic cells to a defined set of CC and CXC chemokines. , 1997, Journal of immunology.

[31]  T. Mcclanahan,et al.  A dendritic-cell-derived C–C chemokine that preferentially attracts naive T cells , 1997, Nature.

[32]  S. Romagnani,et al.  The Th1/Th2 paradigm. , 1997, Immunology today.

[33]  A. Mantovani,et al.  Cytokine regulation of endothelial cell function: from molecular level to the bedside. , 1997, Immunology today.

[34]  O. Götze,et al.  Chemoattractant receptors for interleukin‐8 and C5a: expression on peripheral blood leukocytes and differential regulation on HL‐60 and AML‐193 cells by vitamin D3 and all‐trans rètinoic acid , 1997, European journal of immunology.

[35]  K. Murao,et al.  Regulation of Expression of the Human Monocyte Chemotactic Protein-1 Receptor (hCCR2) by Cytokines* , 1997, The Journal of Biological Chemistry.

[36]  A. Sica,et al.  Bacterial Lipopolysaccharide Rapidly Inhibits Expression of C–C Chemokine Receptors in Human Monocytes , 1997, The Journal of experimental medicine.

[37]  B Dewald,et al.  Human chemokines: an update. , 1997, Annual review of immunology.

[38]  F. DeLeo,et al.  Assembly of the phagocyte NADPH oxidase: molecular interaction of oxidase proteins , 1996, Journal of leukocyte biology.

[39]  A. Tall,et al.  Interleukin 8 Is Induced by Cholesterol Loading of Macrophages and Expressed by Macrophage Foam Cells in Human Atheroma (*) , 1996, The Journal of Biological Chemistry.

[40]  C. Mackay,et al.  Expression of monocyte chemoattractant protein‐1 and interleukin‐8 receptors on subsets of T cells: correlation with transendothelial chemotactic potential , 1996, European journal of immunology.

[41]  L. Notarangelo,et al.  CD30 cell expression and abnormal soluble CD30 serum accumulation in Omenn's syndrome: Evidence for a T helper 2‐mediated condition , 1996, European journal of immunology.

[42]  H. Mizoguchi,et al.  Activation and priming of human monocytes by monocyte chemotactic activating factor: cooperation with other inflammatory cytokines and close association between an increase in cytoplasmic free Ca2+ and intracellular acidification. , 1996, Experimental hematology.

[43]  A. Manning,et al.  TGF-β1, IL-10 and IL-4 differentially modulate the cytokine-induced expression of IL-6 and IL-8 in human endothelial cells , 1996 .

[44]  K. Nilsson,et al.  Monocytes and Macrophages , 1996 .

[45]  F. Luscinskas,et al.  Endothelial-dependent mechanisms in chronic inflammatory leukocyte recruitment. , 1996, Annual review of medicine.

[46]  D. Taub,et al.  Granulocyte-Colony Stimulating Factor and Lipopolysaccharide Regulate the Expression of Interleukin 8 Receptors on Polymorphonuclear Leukocytes (*) , 1995, The Journal of Biological Chemistry.

[47]  P. Ferrara,et al.  Experimental gene therapy of cancer using tumor cells engineered to secrete interleukin‐13 , 1995, European journal of immunology.

[48]  Konrad M. Hartung,et al.  IL-8 is expressed by human peripheral blood eosinophils. Evidence for increased secretion in asthma. , 1995, Journal of immunology.

[49]  K. Fearon,et al.  Interleukin-4 and interleukin-10 increase endotoxin-stimulated human umbilical vein endothelial cell interleukin-8 release. , 1995, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[50]  S. Murakami,et al.  Expression of both types of human interleukin‐8 receptors on mature neutrophils, monocytes, and natural killer cells , 1995, Journal of leukocyte biology.

[51]  A. Chuntharapai,et al.  Monoclonal antibodies detect different distribution patterns of IL-8 receptor A and IL-8 receptor B on human peripheral blood leukocytes. , 1994, Journal of immunology.

[52]  A. Mantovani,et al.  Activation of phospholipase D by interleukin-8 in human neutrophils. , 1994, Blood.

[53]  S. Bernasconi,et al.  Regulation of endothelial and mesothelial cell function by interleukin-13: selective induction of vascular cell adhesion molecule-1 and amplification of interleukin-6 production. , 1994, Blood.

[54]  P. Ferrara,et al.  Interleukin-13 is a monocyte chemoattractant. , 1994, European cytokine network.

[55]  G S Kansas,et al.  Monocyte rolling, arrest and spreading on IL-4-activated vascular endothelium under flow is mediated via sequential action of L-selectin, beta 1-integrins, and beta 2-integrins , 1994, The Journal of cell biology.

[56]  S. Gordon,et al.  Interleukin‐13 alters the activation state of murine macrophages in vitro: Comparison with interleukin‐4 and interferon‐γ , 1994, European journal of immunology.

[57]  A. Mantovani,et al.  Interleukin-13 induces the production of interleukin-1 receptor antagonist (IL-1ra) and the expression of the mRNA for the intracellular (keratinocyte) form of IL-1ra in human myelomonocytic cells. , 1994, Blood.

[58]  T. Springer Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm , 1994, Cell.

[59]  A. Thomson The cytokine handbook , 1994 .

[60]  M. Baggiolini,et al.  Expression of transcripts for two interleukin 8 receptors in human phagocytes, lymphocytes and melanoma cells. , 1993, The Biochemical journal.

[61]  T. Standiford,et al.  Gene expression of macrophage inflammatory protein-1 alpha from human blood monocytes and alveolar macrophages is inhibited by interleukin-4. , 1993, American journal of respiratory cell and molecular biology.

[62]  A. Mantovani,et al.  Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. , 1993, Science.

[63]  S Gordon,et al.  Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation , 1992, The Journal of experimental medicine.

[64]  J. Schröder,et al.  Neutrophil-activating proteins in psoriasis. , 1992, The Journal of investigative dermatology.

[65]  L. Mcphail,et al.  The neutrophil respiratory burst mechanism. , 1992, Immunology series.

[66]  R. Coffey Granulocyte responses to cytokines. Basic and clinical research. , 1992, Immunology series.

[67]  A. Mantovani,et al.  The signal transduction pathway involved in the migration induced by a monocyte chemotactic cytokine. , 1991, Journal of immunology.

[68]  M. Baggiolini,et al.  [Ca2+]i Changes and Respiratory Burst in Human Neutrophils and Monocytes Induced by NAP‐1/Interleukin‐8, NAP‐2, and gro/MGSA , 1991, Journal of leukocyte biology.

[69]  C. Nathan,et al.  Gram‐negative endotoxin: an extraordinary lipid with profound effects on eukaryotic signal transduction 1 , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[70]  S. Becker,et al.  Antagonistic and additive effects of IL-4 and interferon-gamma on human monocytes and macrophages: effects on Fc receptors, HLA-D antigens, and superoxide production. , 1990, Cellular immunology.

[71]  E. Appella,et al.  Properties of monocyte chemotactic and activating factor (MCAF) purified from a human fibrosarcoma cell line , 1990, The Journal of experimental medicine.

[72]  J. Van Damme,et al.  Granulocyte chemotactic protein/interleukin-8 induces plasma leakage and neutrophil accumulation in rabbit skin. , 1989, The American journal of pathology.

[73]  P. Hart,et al.  Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor alpha, interleukin 1, and prostaglandin E2. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[74]  B. Dewald,et al.  In vivo inflammatory activity of neutrophil-activating factor, a novel chemotactic peptide derived from human monocytes. , 1989, The American journal of pathology.

[75]  M. Baggiolini,et al.  Mechanism of neutrophil activation by NAF, a novel monocyte‐derived peptide agonist , 1988, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[76]  B. Babior The respiratory burst oxidase. , 1988, Hematology/oncology clinics of North America.

[77]  B. Dewald,et al.  A novel neutrophil-activating factor produced by human mononuclear phagocytes , 1988, The Journal of experimental medicine.

[78]  J. van Beeumen,et al.  A novel, NH2-terminal sequence-characterized human monokine possessing neutrophil chemotactic, skin-reactive, and granulocytosis-promoting activity , 1988, The Journal of experimental medicine.

[79]  R. Johnston Current concepts: immunology. Monocytes and macrophages. , 1988, The New England journal of medicine.

[80]  C. Nathan,et al.  Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity , 1983, The Journal of experimental medicine.

[81]  C. Werning [Rheumatoid arthritis]. , 1983, Medizinische Monatsschrift fur Pharmazeuten.